Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy

BackgroundStudies in small animals and human patients have suggested that anthracyclines may prolong cardiac repolarization, or at least inhibit repolarization reserve, predisposing to QT prolongation and dangerous arrhythmias such as Torsades de pointes. This association in humans is difficult to c...

Full description

Bibliographic Details
Main Authors: George M. Bodziock, Giselle C. Meléndez
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1247273/full
_version_ 1797393409449656320
author George M. Bodziock
Giselle C. Meléndez
Giselle C. Meléndez
author_facet George M. Bodziock
Giselle C. Meléndez
Giselle C. Meléndez
author_sort George M. Bodziock
collection DOAJ
description BackgroundStudies in small animals and human patients have suggested that anthracyclines may prolong cardiac repolarization, or at least inhibit repolarization reserve, predisposing to QT prolongation and dangerous arrhythmias such as Torsades de pointes. This association in humans is difficult to confirm due to multiple confounding variables such as the presence of other medications and concurrent illness.ObjectivesIdentify a long-term association between anthracycline administration and repolarization prolongation in nonhuman primates, which can be measured as prolonged QT/QTc intervals on surface electrocardiogram.MethodsFive female African Green monkeys (AGMs) aged 13 ± 1 years received Doxorubicin (Dox) at doses similar to women treated for breast cancer (30–60 mg/m2/biweekly IV, total cumulative dose: 240 mg/m2) and underwent 12-lead electrocardiogram (ECG) before and 15 weeks after the final dose of Dox treatment. A blinded paired analysis was performed on ECG derived heart rate (HR), QRS, QT and QT corrected for HR (QTc) interval durations.ResultsAfter Dox, all monkeys exhibited increased QT (BL: 323.2 ± 27.4 ms vs. Post-Dox: 366.4 ± 18.7 ms, p = 0.002) and QTc (BL: 440.2 ± 22.8 ms vs. Post-Dox: 500.8 ± 22.0 ms, p = 0.009) intervals, without any significant changes in HR or QRS duration (p = 0.92 and p = 0.47 respectively).ConclusionsAGMs treated with Dox exhibited long-term QT and QTc prolongation, along with the expected cardiotoxicity (LVEF decrease). While similar findings were shown in small animal studies, confounders make human association difficult to prove. Our finding provides a valuable intermediary step, showing direct effect of Dox on repolarization in nonhuman primates.
first_indexed 2024-03-09T00:02:10Z
format Article
id doaj.art-8f1a1cd00a184d7bb83a9083f4a37695
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-09T00:02:10Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-8f1a1cd00a184d7bb83a9083f4a376952023-12-12T16:39:22ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-12-011010.3389/fcvm.2023.12472731247273Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapyGeorge M. Bodziock0Giselle C. Meléndez1Giselle C. Meléndez2Department of Internal Medicine, Section of Cardiovascular Medicine, Cardiac Electrophysiology, Wake Forest University School of Medicine, Winston-Salem, NC, United StatesDepartment of Internal Medicine, Section of Cardiovascular Medicine, Cardiac Electrophysiology, Wake Forest University School of Medicine, Winston-Salem, NC, United StatesDepartment of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United StatesBackgroundStudies in small animals and human patients have suggested that anthracyclines may prolong cardiac repolarization, or at least inhibit repolarization reserve, predisposing to QT prolongation and dangerous arrhythmias such as Torsades de pointes. This association in humans is difficult to confirm due to multiple confounding variables such as the presence of other medications and concurrent illness.ObjectivesIdentify a long-term association between anthracycline administration and repolarization prolongation in nonhuman primates, which can be measured as prolonged QT/QTc intervals on surface electrocardiogram.MethodsFive female African Green monkeys (AGMs) aged 13 ± 1 years received Doxorubicin (Dox) at doses similar to women treated for breast cancer (30–60 mg/m2/biweekly IV, total cumulative dose: 240 mg/m2) and underwent 12-lead electrocardiogram (ECG) before and 15 weeks after the final dose of Dox treatment. A blinded paired analysis was performed on ECG derived heart rate (HR), QRS, QT and QT corrected for HR (QTc) interval durations.ResultsAfter Dox, all monkeys exhibited increased QT (BL: 323.2 ± 27.4 ms vs. Post-Dox: 366.4 ± 18.7 ms, p = 0.002) and QTc (BL: 440.2 ± 22.8 ms vs. Post-Dox: 500.8 ± 22.0 ms, p = 0.009) intervals, without any significant changes in HR or QRS duration (p = 0.92 and p = 0.47 respectively).ConclusionsAGMs treated with Dox exhibited long-term QT and QTc prolongation, along with the expected cardiotoxicity (LVEF decrease). While similar findings were shown in small animal studies, confounders make human association difficult to prove. Our finding provides a valuable intermediary step, showing direct effect of Dox on repolarization in nonhuman primates.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1247273/fullantracyclinesQT prolongationmonkeysrepolarization reservecardiomyopathyTorsade de point
spellingShingle George M. Bodziock
Giselle C. Meléndez
Giselle C. Meléndez
Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy
Frontiers in Cardiovascular Medicine
antracyclines
QT prolongation
monkeys
repolarization reserve
cardiomyopathy
Torsade de point
title Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy
title_full Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy
title_fullStr Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy
title_full_unstemmed Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy
title_short Long-term QT prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy
title_sort long term qt prolongation in monkeys after doxorubicin administration at doses similar to breast cancer therapy
topic antracyclines
QT prolongation
monkeys
repolarization reserve
cardiomyopathy
Torsade de point
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1247273/full
work_keys_str_mv AT georgembodziock longtermqtprolongationinmonkeysafterdoxorubicinadministrationatdosessimilartobreastcancertherapy
AT gisellecmelendez longtermqtprolongationinmonkeysafterdoxorubicinadministrationatdosessimilartobreastcancertherapy
AT gisellecmelendez longtermqtprolongationinmonkeysafterdoxorubicinadministrationatdosessimilartobreastcancertherapy